<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335510</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Impact of Hyponatremia on COVID-19-Related Outcomes: A Retrospective Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1997</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12091997</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sodium disturbances are observed in one-third of patients with COVID-19 and result from multifaceted mechanisms. Notably, hyponatremia is associated with disease progression and mortality.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">We aimed to analyze the impact of hyponatremia on COVID-19 outcomes and its correlation with clinical and laboratory parameters during the first wave.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We evaluated the sodium levels of 558 patients with COVID-19 between 21 March 2020, and 31 July 2020, at a single center. We performed linear regression analyses to explore the correlation of sodium levels with COVID-19-related outcomes, demographic data, signs and symptoms, and laboratory parameters. Next, we conducted Pearson correlation analyses. A <i>p</i>-value &lt; 0.05 was considered significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Hyponatremia was found in 35.3% of hospitalized patients with COVID-19. This was associated with the need for intensive care transfer (B = -1.210, <i>p</i> = 0.009) and invasive mechanical ventilation (B = -1.063, <i>p</i> = 0.032). Hyponatremia was frequently found in oncologic patients (<i>p</i> = 0.002) and solid organ transplant recipients (<i>p</i> &lt; 0.001). Sodium was positively associated with diastolic blood pressure (<i>p</i> = 0.041) and productive cough (<i>p</i> = 0.022) and negatively associated with dry cough (<i>p</i> = 0.032), anorexia (<i>p</i> = 0.004), and nausea/vomiting (<i>p</i> = 0.007). Regarding the correlation of sodium levels with other laboratory parameters, we observed a positive correlation with hematocrit (<i>p</i> = 0.011), lymphocytes (<i>p</i> = 0.010), pCO<sub>2</sub> (<i>p</i> &lt; 0.0001), bicarbonate (<i>p</i> = 0.0001), and base excess (<i>p</i> = 0.008) and a negative correlation with the neutrophil-to-lymphocyte ratio (<i>p</i> = 0.009), the platelet-to-lymphocyte ratio (<i>p</i> = 0.033), and arterial blood glucose (<i>p</i> = 0.016).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hyponatremia is a risk factor for adverse outcomes in COVID-19 patients. It is associated with demographic data and clinical and laboratory parameters. Therefore, hyponatremia is an important tool for risk stratification in COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piza</LastName><ForeName>Pedro Maciel de Toledo</ForeName><Initials>PMT</Initials><Identifier Source="ORCID">0009-0003-1403-376X</Identifier><AffiliationInfo><Affiliation>Paulista School of Medicine, Federal University of São Paulo, São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Freitas</LastName><ForeName>Victor Muniz</ForeName><Initials>VM</Initials><Identifier Source="ORCID">0000-0002-3842-818X</Identifier><AffiliationInfo><Affiliation>Paulista School of Medicine, Federal University of São Paulo, São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguiar-Brito</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5318-7153</Identifier><AffiliationInfo><Affiliation>Paulista School of Medicine, Federal University of São Paulo, São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calsolari-Oliveira</LastName><ForeName>Barbara Monique</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Paulista School of Medicine, Federal University of São Paulo, São Paulo 04023-062, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangel</LastName><ForeName>Érika Bevilaqua</ForeName><Initials>ÉB</Initials><Identifier Source="ORCID">0000-0003-0982-2484</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Nephrology Division, Federal University of São Paulo, São Paulo 04038-031, SP, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Israelita de Ensino e Pesquisa Albert Einstein, Hospital Israelita Albert Einstein, São Paulo 05652-900, SP, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">hyponatremia</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">sodium</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335510</ArticleId><ArticleId IdType="pmc">PMC11444129</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12091997</ArticleId><ArticleId IdType="pii">biomedicines12091997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuinness L., Clarke E.L., Wade R.G. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE. 2020;15:e0234765. doi: 10.1371/journal.pone.0234765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234765</ArticleId><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel E.B. COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J Clin. Microbiol. Infect. Dis. 2021;40:905–919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 2022;20:270–284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani O.T., Bastos L.S.L., Gelli J.G.M., Marchesi J.F., Baião F., Hamacher S.A., Bozza F. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: A retrospective analysis of nationwide data. Lancet Respir. Med. 2021;9:407–418. doi: 10.1016/S2213-2600(20)30560-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30560-9</ArticleId><ArticleId IdType="pmc">PMC7834889</ArticleId><ArticleId IdType="pubmed">33460571</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaan F., Carneiro de P.E., de Lima Souza F.B.G., Mendes L.F.C., Rossi P.R.G., Freitas R.A.P., Nakagawa F.T., Maciel A.T., Aranha S., Osawa E., et al. COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: A multicenter study in Sao Paulo, Brazil. PLoS ONE. 2022;17:e0261958. doi: 10.1371/journal.pone.0261958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261958</ArticleId><ArticleId IdType="pmc">PMC8759670</ArticleId><ArticleId IdType="pubmed">35030179</ArticleId></ArticleIdList></Reference><Reference><Citation>De Freitas V.M., Chiloff D.M., Bosso G.G., Teixeira J.O.P., Hernandes I.C.d.G., Padilha M.D.P., Moura G.C., De Andrade L.G.M., Mancuso F., Finamor F.E., et al. A Machine Learning Model for Predicting Hospitalization in Patients with Respiratory Symptoms during the COVID-19 Pandemic. J. Clin. Med. 2022;11:4574. doi: 10.3390/jcm11154574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11154574</ArticleId><ArticleId IdType="pmc">PMC9369854</ArticleId><ArticleId IdType="pubmed">35956189</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B.G., Aghagoli G., Lavine K., Yang L., Siff E.J., Chiang S.S., Salazar-Mather T.P., Dumenco L., Savaria M.C., Aung S.N., et al. Predictors of COVID-19 severity: A literature review. Rev. Med. Virol. 2021;31:1–10. doi: 10.1002/rmv.2146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2146</ArticleId><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargava A., Fukushima E.A., Levine M., Zhao W., Tanveer F., Szpunar S.M., Saravolatz L. Predictors for Severe COVID-19 Infection. Clin. Infect. Dis. 2020;71:1962–1968. doi: 10.1093/cid/ciaa674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa674</ArticleId><ArticleId IdType="pmc">PMC7314166</ArticleId><ArticleId IdType="pubmed">32472676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch J.S., Uppal N.N., Sharma P., Khanin Y., Shah H.H.A., Malieckal D., Bellucci A., Mala Sachdeva M., Rondon-Berrios H., Jhaveri K.D., et al. Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19. Nephrol. Dial. Transplant. 2021;36:1135–1138. doi: 10.1093/ndt/gfab067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfab067</ArticleId><ArticleId IdType="pmc">PMC7989196</ArticleId><ArticleId IdType="pubmed">33724428</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho H., Letellier T., Karakachoff M., Desvaux G., Caillon H., Papuchon E., Bentoumi-Loaec M., Benaouicha N., Canet E., Chapelet G., et al. Hyponatremia is associated with poor outcome in COVID-19. J. Nephrol. 2021;34:991–998. doi: 10.1007/s40620-021-01036-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-021-01036-8</ArticleId><ArticleId IdType="pmc">PMC8025067</ArticleId><ArticleId IdType="pubmed">33826113</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G., Giuliani C., Parenti G., Norello D., Verbalis J.G., Forti G., Maggi M., Peri A. Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis. PLoS ONE. 2013;8:e80451. doi: 10.1371/journal.pone.0080451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080451</ArticleId><ArticleId IdType="pmc">PMC3867320</ArticleId><ArticleId IdType="pubmed">24367479</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrogue H.J., Tucker B.M., Madias N.E. Diagnosis and Management of Hyponatremia: A Review. JAMA. 2022;328:280–291. doi: 10.1001/jama.2022.11176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11176</ArticleId><ArticleId IdType="pubmed">35852524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheorghe G., Ilie M., Bungau S., Stoian A.M.P., Bacalbasa N., Diaconu C.C. Is There a Relationship between COVID-19 and Hyponatremia? Medicina. 2021;57:55. doi: 10.3390/medicina57010055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57010055</ArticleId><ArticleId IdType="pmc">PMC7827825</ArticleId><ArticleId IdType="pubmed">33435405</ArticleId></ArticleIdList></Reference><Reference><Citation>Khidir R.J.Y., Ibrahim B.A.Y., Adam M.H.M., Hassan R.M.E., Fedail A.S.S., Abdulhamid R.O., Mohamed S.O.O. Prevalence and outcomes of hyponatremia among COVID-19 patients: A systematic review and meta-analysis. Int J Health Sci. 2022;16:69–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9441642</ArticleId><ArticleId IdType="pubmed">36101848</ArticleId></ArticleIdList></Reference><Reference><Citation>Javaid M.M., Shan J., Frederick R., Dreyer R., Gome J.J. Hyponatremia in COVID-19 Is Not Always Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH): A Case Series. Cureus. 2022;14:e30939. doi: 10.7759/cureus.30939.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.30939</ArticleId><ArticleId IdType="pmc">PMC9712031</ArticleId><ArticleId IdType="pubmed">36465769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanghani H., Bansal S., Parmar V., Shah R. Study of Arterial Blood Gas Analysis in Moderate-to-Severe COVID-19 Patients. Cureus. 2022;14:e26715. doi: 10.7759/cureus.26715.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.26715</ArticleId><ArticleId IdType="pmc">PMC9362693</ArticleId><ArticleId IdType="pubmed">35967170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Han Z., Heidari A.A., Shou Y., Ye H., Wang L., Huang X., Chen H., Chen Y., Wu P. Detection of COVID-19 severity using blood gas analysis parameters and Harris hawks optimized extreme learning machine. Comput. Biol. Med. 2021;142:105166. doi: 10.1016/j.compbiomed.2021.105166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105166</ArticleId><ArticleId IdType="pmc">PMC8701842</ArticleId><ArticleId IdType="pubmed">35077935</ArticleId></ArticleIdList></Reference><Reference><Citation>Berni A., Malandrino D., Parenti G., Maggi M., Poggesi L., Peri A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: May all fit together? J. Endocrinol. Investig. 2020;43:1137–1139. doi: 10.1007/s40618-020-01301-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01301-w</ArticleId><ArticleId IdType="pmc">PMC7246958</ArticleId><ArticleId IdType="pubmed">32451971</ArticleId></ArticleIdList></Reference><Reference><Citation>Swart R.M., Hoorn E.J., Betjes M.G., Zietse R. Hyponatremia and Inflammation: The Emerging Role of Interleukin-6 in Osmoregulation. Nephron Physiol. 2010;118:45–51. doi: 10.1159/000322238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000322238</ArticleId><ArticleId IdType="pubmed">21196778</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L., Wang Q., Zhang D., Ding J., Huang Q., Tang Y.Q., Wang Q., Miao H. Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study. Signal. Transduct. Target Ther. 2020;5:33. doi: 10.1038/s41392-020-0148-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0148-4</ArticleId><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li S., Liu J., Liang B., Wang X., Wang H., Li W., Tong Q., Yi J., Zhao L., et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. eBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId><ArticleId IdType="pmc">PMC7165294</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobcakova A., Petriskova J., Vysehradsky R., Kocan I., Kapustova L., Barnova M., Diamant Z., Jesenak M. Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome. Front. Cell. Infect. Microbiol. 2021;11:646688. doi: 10.3389/fcimb.2021.646688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.646688</ArticleId><ArticleId IdType="pmc">PMC8082075</ArticleId><ArticleId IdType="pubmed">33937096</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020;71:762–768. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Jones S., Vangeti S., Yu M., Falck-Jones R., Cagigi A., Badolati I., Österberg B., Lautenbach M.J., Åhlberg E., Lin A., et al. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. J. Clin. Investig. 2021;131:e144734. doi: 10.1172/JCI144734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI144734</ArticleId><ArticleId IdType="pmc">PMC7954608</ArticleId><ArticleId IdType="pubmed">33492309</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang I., Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J. Intensive Care. 2020;8:36. doi: 10.1186/s40560-020-00453-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-020-00453-4</ArticleId><ArticleId IdType="pmc">PMC7245646</ArticleId><ArticleId IdType="pubmed">32483488</ArticleId></ArticleIdList></Reference><Reference><Citation>Reusch N., De Domenico E., Bonaguro L., Schulte-Schrepping J., Baßler K., Schultze J.L., Aschenbrenner A.C. Neutrophils in COVID-19. Front. Immunol. 2021;12:652470. doi: 10.3389/fimmu.2021.652470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.652470</ArticleId><ArticleId IdType="pmc">PMC8027077</ArticleId><ArticleId IdType="pubmed">33841435</ArticleId></ArticleIdList></Reference><Reference><Citation>Prozan L., Shusterman E., Ablin J., Mitelpunkt A., Weiss-Meilik A., Adler A., Choshen G., Kehat O. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection. Sci. Rep. 2021;11:21519. doi: 10.1038/s41598-021-00927-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00927-x</ArticleId><ArticleId IdType="pmc">PMC8563769</ArticleId><ArticleId IdType="pubmed">34728719</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu A.A., Mangoni A. A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality. Expert Rev. Clin. Immunol. 2022;18:1187–1202. doi: 10.1080/1744666X.2022.2120472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2022.2120472</ArticleId><ArticleId IdType="pubmed">36047369</ArticleId></ArticleIdList></Reference><Reference><Citation>Delshad M., Safaroghli-Azar A., Pourbagheri-Sigaroodi A., Poopak B., Shokouhi S., Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int. Immunopharmacol. 2021;99:107995. doi: 10.1016/j.intimp.2021.107995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107995</ArticleId><ArticleId IdType="pmc">PMC8295197</ArticleId><ArticleId IdType="pubmed">34304001</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Kannan S., Khanna P., Singh A.K. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J. Med. Virol. 2022;94:211–221. doi: 10.1002/jmv.27297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27297</ArticleId><ArticleId IdType="pmc">PMC8661888</ArticleId><ArticleId IdType="pubmed">34436785</ArticleId></ArticleIdList></Reference><Reference><Citation>Huyut M., Üstündağ H. Prediction of diagnosis and prognosis of COVID-19 disease by blood gas parameters using decision trees machine learning model: A retrospective observational study. Med. Gas Res. 2022;12:60–66. doi: 10.4103/2045-9912.326002.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2045-9912.326002</ArticleId><ArticleId IdType="pmc">PMC8562394</ArticleId><ArticleId IdType="pubmed">34677154</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A., Tellone E., Barreca D., Ficarra S., Laganà G. Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects. Int. J. Mol. Sci. 2022;23:2171. doi: 10.3390/ijms23042171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042171</ArticleId><ArticleId IdType="pmc">PMC8878454</ArticleId><ArticleId IdType="pubmed">35216286</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbudi A., Rahmadika N., Tjahjadi A.I., Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr. Diabetes Rev. 2020;16:442–449. doi: 10.2174/1573399815666191024085838.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573399815666191024085838</ArticleId><ArticleId IdType="pmc">PMC7475801</ArticleId><ArticleId IdType="pubmed">31657690</ArticleId></ArticleIdList></Reference><Reference><Citation>Muniyappa R., Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 2020;318:E736–E741. doi: 10.1152/ajpendo.00124.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00124.2020</ArticleId><ArticleId IdType="pmc">PMC7191633</ArticleId><ArticleId IdType="pubmed">32228322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C., Marfella R., Prattichizzo F., La Grotta R., Paolisso G., Ceriello A. Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms. J. Clin. Med. 2022;11:1564. doi: 10.3390/jcm11061564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061564</ArticleId><ArticleId IdType="pmc">PMC8955791</ArticleId><ArticleId IdType="pubmed">35329890</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiterer M., Rajan M., Gomez-Banoy N., Lau J.D., Gomez-Escobar L.G., Ma L., Gilani A., Alvarez-Mulett S., Sholle E.T., Chandar V., et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021;33:2174–2188. doi: 10.1016/j.cmet.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8443335</ArticleId><ArticleId IdType="pubmed">34599884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.T., Lidsky P.V., Xiao Y., Lee I.T., Cheng R., Nakayama T., Jiang S., Demeter J., Bevacqua R.J., Chang C.A., et al. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab. 2021;33:1565–1576. doi: 10.1016/j.cmet.2021.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., She Z.-G., Cheng X., Qin J.-J., Zhang X.-J., Cai J., Lei F., Wang H., Xie J., Wang W., et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020;31:1068–1077.e3. doi: 10.1016/j.cmet.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel B., de Lucena D.D., Aguiar-Brito I., de Andrade L.G.M., Veronese-Araújo A., Cristelli M.P., Tedesco-Silva H., Medina-Pestana J.O. COVID-19 in Kidney Transplant Recipients With Diabetes Mellitus: A Propensity Score Matching Analysis. Transpl. Int. 2022;35:10375. doi: 10.3389/ti.2022.10375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ti.2022.10375</ArticleId><ArticleId IdType="pmc">PMC9357874</ArticleId><ArticleId IdType="pubmed">35957939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wu C., Wang X., Yu J., Sun Z. The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis. Front. Endocrinol. 2020;11:574541. doi: 10.3389/fendo.2020.574541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.574541</ArticleId><ArticleId IdType="pmc">PMC7570435</ArticleId><ArticleId IdType="pubmed">33123093</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalakis K., Ilias I. COVID-19 and hyperglycemia/diabetes. World J. Diabetes. 2021;12:642–650. doi: 10.4239/wjd.v12.i5.642.</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v12.i5.642</ArticleId><ArticleId IdType="pmc">PMC8107977</ArticleId><ArticleId IdType="pubmed">33995851</ArticleId></ArticleIdList></Reference><Reference><Citation>Liamis G., Liberopoulos E., Barkas F., Elisaf M. Diabetes mellitus and electrolyte disorders. World J. Clin. Cases. 2014;2:488–496. doi: 10.12998/wjcc.v2.i10.488.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v2.i10.488</ArticleId><ArticleId IdType="pmc">PMC4198400</ArticleId><ArticleId IdType="pubmed">25325058</ArticleId></ArticleIdList></Reference><Reference><Citation>Woyesa S.B., Gebisa W.C., Anshebo D.L. Assessment of Selected Serum Electrolyte and Associated Risk Factors in Diabetic Patients. Diabetes Metab. Syndr. Obesity Targets Ther. 2020;2019:2811–2817. doi: 10.2147/DMSO.S233053.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S233053</ArticleId><ArticleId IdType="pmc">PMC6978677</ArticleId><ArticleId IdType="pubmed">32021344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmo A.M., Gardiner D.M., Ushiro-Lumb I.M., Ravanan R.M., Forsythe J.L.R.M. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation. 2022;106:1312–1329. doi: 10.1097/TP.0000000000004151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004151</ArticleId><ArticleId IdType="pmc">PMC9213067</ArticleId><ArticleId IdType="pubmed">35404911</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinato D.J., Patel M., Scotti L., Colomba E., Dolly S., Loizidou A., Chester J., Mukherjee U., Zambelli A., Dalla P.A., et al. Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. JAMA Oncol. 2022;8:114–122. doi: 10.1001/jamaoncol.2021.619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2021.619</ArticleId><ArticleId IdType="pmc">PMC8777559</ArticleId><ArticleId IdType="pubmed">34817562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel E.B. The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation. Expert Opin. Drug Metab. Toxicol. 2012;8:1531–1548. doi: 10.1517/17425255.2012.724058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425255.2012.724058</ArticleId><ArticleId IdType="pubmed">22978385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuderer N.M., Desai A., Lustberg M.B., Lyman G.H. Mitigating acute chemotherapy-associated adverse events in patients with cancer. Nat. Rev. Clin. Oncol. 2022;19:681–697. doi: 10.1038/s41571-022-00685-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-022-00685-3</ArticleId><ArticleId IdType="pubmed">36221000</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaga S., Shimata K., Ohfuji S., Yoshikawa M., Natori Y., Hibi T., Yuzawa K., Egawa H., Unagami K., Ishida H., et al. Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic. Am. J. Transplant. 2024;24:1495–1508. doi: 10.1016/j.ajt.2024.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2024.03.016</ArticleId><ArticleId IdType="pubmed">38514016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharafeldin N., Bates B., Song Q., Madhira V., Yan Y., Dong S., Lee E., Kuhrt N., Shao Y.R., Liu F., et al. Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C) J. Clin. Oncol. 2021;39:2232–2246. doi: 10.1200/JCO.21.01074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.21.01074</ArticleId><ArticleId IdType="pmc">PMC8260918</ArticleId><ArticleId IdType="pubmed">34085538</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>